Claims for Patent: 9,155,738

Summary for Patent: 9,155,738

Title:	Compounds for use in treatment of mucostitis
Abstract:	The present invention provides methods for treating and/or preventing mucostitis with one or more compounds, or pharmaceutically acceptable salts thereof, disclosed herein, or compositions comprising the same.
Inventor(s):	Scott; Richard W. (Radnor, PA), Korczak; Bozena (Wayne, PA)
Assignee:	Cellceutix Corporation (Beverly, MA)
Application Number:	14/456,202
Patent Claims:	1. A method of treating mucositis in a human comprising administering to the human in need thereof a therapeutically effective amount of a compound having the formula ##STR00552## or a pharmaceutically acceptable salt thereof. 2. The method of claim 1 wherein the human is administered a pharmaceutical composition comprising the compound, or pharmaceutically acceptable salt thereof. 3. The method of claim 2 wherein the pharmaceutical composition further comprises another therapeutic agent. 4. The method of claim 3 wherein the another therapeutic agent is palifermin. 5. The method of claim 1 wherein the human also receives chemotherapy, radiation therapy, or both, for treatment of cancer. 6. The method of claim 2 wherein the pharmaceutical composition is administered orally, bucally, or sublingually. 7. The method of claim 2 wherein the pharmaceutical composition is a liquid. 8. The method of claim 2 wherein the pharmaceutical composition is a rinse. 9. The method of claim 8 wherein the compound in the rinse is at 1 mg/ml. 10. The method of claim 8 wherein the compound in the rinse is at 3 mg/ml. 11. The method of claim 8 wherein the compound in the rinse is at 10 mg/ml. 12. A method of treating mucositis in a human comprising administering orally, bucally, or sublingually to the human in need thereof a liquid pharmaceutical composition comprising 1 mg/ml of a compound having the formula ##STR00553## or a pharmaceutically acceptable salt thereof. 13. The method of claim 12 wherein the pharmaceutical composition is a rinse. 14. The method of claim 13 wherein the rinse comprises 3 mg/ml of the compound, or pharmaceutically acceptable salt thereof. 15. The method of claim 13 wherein the rinse comprises 10 mg/ml of the compound, or pharmaceutically acceptable salt thereof. 16. A method of treating mucositis in a human comprising administering orally, bucally, or sublingually to the human in need thereof a liquid pharmaceutical composition in the form of a rinse comprising 1 mg/ml of a compound having the formula ##STR00554## or a pharmaceutically acceptable salt thereof.

Details for Patent 9,155,738

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Swedish Orphan Biovitrum Ab (publ)	KEPIVANCE	palifermin	For Injection	125103	12/15/2004		2031-05-16